EU approves the bloc’s first vaccine for RSV



The European Commission authorized on Wednesday the use of the bloc’s first vaccine for the respiratory syncytial virus (RSV) which causes about 250,000 hospitalizations and 17,000 in-hospital dea…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento